Literature DB >> 17482951

Ureteropelvic junction obliteration resulting in nephrectomy after radiofrequency ablation of small renal cell carcinoma.

Stephanie H Chen1, Vladimir Mouraviev, Ganesh V Raj, Charles G Marguet, Thomas J Polascik.   

Abstract

Percutaneous radiofrequency ablation is a minimally invasive treatment that is currently used to treat renal tumors. Despite its minimally invasive nature, potential serious complications can occur. We report the second case of ureteropelvic junction obstruction after radiofrequency ablation that resulted in nephrectomy. The use of radiofrequency ablation should be considered with caution, particularly when tumors are centrally located or abut the renal pelvis. Additional data are needed to better define the indications and contraindications to minimally invasive ablative technologies when used in the clinical setting.

Entities:  

Mesh:

Year:  2007        PMID: 17482951     DOI: 10.1016/j.urology.2007.02.031

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  Risk Factors of Ureteral Stenosis After Percutaneous Microwave Ablation of Renal Tumor, a Single-Center Experience.

Authors:  Jiapeng Wu; Jie Yu; Zhigang Cheng; Zhiyu Han; Xiaoling Yu; Kai Li; Ping Hu; Fangyi Liu; Ping Liang
Journal:  Front Oncol       Date:  2020-09-18       Impact factor: 6.244

Review 2.  Computed tomography and magnetic resonance imaging appearance of renal neoplasms after radiofrequency ablation and cryoablation.

Authors:  Satomi Kawamoto; Stephen B Solomon; David A Bluemke; Elliot K Fishman
Journal:  Semin Ultrasound CT MR       Date:  2009-04       Impact factor: 1.875

Review 3.  Percutaneous ablation of the small renal mass-techniques and outcomes.

Authors:  Andrew J Gunn; Debra A Gervais
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

Review 4.  Imaging considerations for thermal and radiotherapy ablation of primary and metastatic renal cell carcinoma.

Authors:  Mohammad Haroon; Paul Sathiadoss; Rebecca M Hibbert; Satheesh Krishna Jeyaraj; Christopher Lim; Nicola Schieda
Journal:  Abdom Radiol (NY)       Date:  2021-07-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.